(CHE) Chemed - Ratings and Ratios

Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US16359R1032

CHE: Healthcare, Plumbing, Hospice, Palliative, Counseling, Restoration

Chemed Corporation (NYSE:CHE) operates two distinct business segments: VITAS Healthcare and Roto-Rooter. VITAS Healthcare is a leading provider of end-of-life care, offering hospice and palliative services to patients across the United States. This segment delivers comprehensive care through a multidisciplinary team of physicians, nurses, social workers, chaplains, and volunteers, ensuring patients and their families receive medical, emotional, and spiritual support. The Roto-Rooter segment provides essential plumbing, drain cleaning, excavation, water restoration, and related services to residential and commercial customers. This segment utilizes a network of company-owned branches, independent contractors, and franchisees to maintain its market presence.

Chemed Corporation was founded in 1970 and is headquartered in Cincinnati, Ohio. The company has established itself as a key player in both healthcare services and plumbing solutions, with a strong operational footprint across the U.S. Its dual-segment business model allows for diversification, balancing the stable demand for hospice care with the cyclical nature of plumbing services. Web URL: https://www.chemed.com

Ticker Symbol: CHE Exchange: NYSE Type: common stock Country Origin: United States GICS Sub Industry: Health Care Services

3-Month Forecast: Based on and , Chemed Corp is expected to maintain its upward momentum. The SMA 20 (594.60) is slightly above the SMA 50 (586.11), indicating short-term strength. However, the SMA 200 (568.06) suggests long-term bullishness. ATR (13.90) signals moderate volatility. From a perspective, the P/E (28.34) and P/E Forward (23.09) indicate a premium valuation, supported by strong RoE (29.25). The P/S (3.39) reflects stable revenue generation. Market cap (8237.14M USD) and P/B (7.60) highlight investor confidence in the companys dual-segment growth strategy.

Additional Sources for CHE Stock

CHE Stock Overview

Market Cap in USD 8,122m
Sector Healthcare
Industry Medical Care Facilities
GiC Sub-Industry Health Care Services
IPO / Inception 1973-05-03

CHE Stock Ratings

Growth Rating 44.4
Fundamental 83.8
Dividend Rating 53.5
Rel. Strength 2.97
Analysts 4.67/5
Fair Price Momentum 555.12 USD
Fair Price DCF 657.24 USD

CHE Dividends

Dividend Yield 12m 0.33%
Yield on Cost 5y 0.46%
Annual Growth 5y 6.40%
Payout Consistency 97.0%

CHE Growth Ratios

Growth Correlation 3m 36.6%
Growth Correlation 12m 28.5%
Growth Correlation 5y 79%
CAGR 5y 6.96%
CAGR/Max DD 5y 0.26
Sharpe Ratio 12m 0.57
Alpha -4.04
Beta 0.174
Volatility 21.83%
Current Volume 113.8k
Average Volume 20d 124.1k
What is the price of CHE stocks?
As of May 02, 2025, the stock is trading at USD 573.74 with a total of 113,752 shares traded.
Over the past week, the price has changed by +4.93%, over one month by -7.25%, over three months by +3.43% and over the past year by +1.70%.
Is Chemed a good stock to buy?
Yes, based on ValueRay Fundamental Analyses, Chemed (NYSE:CHE) is currently (May 2025) a good stock to buy. It has a ValueRay Fundamental Rating of 83.78 and therefor a positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of CHE as of May 2025 is 555.12. This means that CHE is currently overvalued and has a potential downside of -3.25%.
Is CHE a buy, sell or hold?
Chemed has received a consensus analysts rating of 4.67. Therefor, it is recommend to buy CHE.
  • Strong Buy: 2
  • Buy: 1
  • Hold: 0
  • Sell: 0
  • Strong Sell: 0
What are the forecast for CHE stock price target?
According to ValueRays Forecast Model, CHE Chemed will be worth about 601.5 in May 2026. The stock is currently trading at 573.74. This means that the stock has a potential upside of +4.83%.
Issuer Forecast Upside
Wallstreet Target Price 675 17.6%
Analysts Target Price 663.7 15.7%
ValueRay Target Price 601.5 4.8%